News
age-related macular degeneration
Higher serum vitamin D levels play a role in stages of AMD
Researchers recently examined data from the National Health and Nutrition Examination Survey (NHANES) to determine the link between serum vitamin D levels and the odds of developing different subt...
age-related macular degeneration
Macular degeneration linked to obesity
Researchers were examining why some people with a genetic predisposition develop age-related macular degeneration (AMD) while others with the genetic predisposition do not.
age-related macular degeneration
Lab-grown retinal cells indicate possibility of clinical trials
Researchers hope that these cells are ready to be studied in human clinical trials
age related macular degeneration
Genetic link between COVID risk and macular-degeneration
Researchers analyzed genetic data from more than 16,000 people with AMD, more than 50,000 people with COVID along with control groups.
age-related macular degeneration
Anti-VEGF treatment for wet AMD may hasten progression of glaucoma
Researchers concluded that anti-VEGF treatments do raise the risk of glaucoma progression.
age related macular degeneration
Reduced risk of developing macular degeneration associated with two common prescription drugs
Researchers examined data from 14 studies to determine the effect of drugs on the risk of developing AMD.
age related macular degeneration
Smokers can develop age-related macular degeneration earlier than non-smokers
To better protect overall health, including eye health, WHO encourages people to not use tobacco or e-cigarettes and for those who do use these products, they are encouraged to quit.
age-related macular degeneration
Simple carbs may increase risk of developing macular degeneration
Researchers at Tufts University in Boston have found a possible link between a diet high in simple carbohydrates and risk of developing age-related macular degeneration.
age related macular degeneration
Researchers successfully implant iPS cells in new dry eye therapy
The patient receiving the implant was a part of a clinical trial in the United States and is in the phase 1/2a to determine the therapy's safety.